Montagu Announces Merger of Tyber Medical, Intech, and Resolve to Transform Medical Device Sector
In a groundbreaking move for the medical device landscape, Montagu has revealed plans to support a merger between three key players: Tyber Medical, Intech, and Resolve Surgical Technologies. This strategic merger is set to create a formidable, next-generation supplier in the medical devices market. Tyber Medical is renowned for its innovative offerings in orthopaedic devices and private label development, while Intech excels in complex orthopedic surgical devices, and Resolve is recognized for its lifecycle management services in contract manufacturing.
The merger is part of Montagu's vision to enhance efficiency and accelerate the speed at which medical technologies reach the market. With regulatory approvals pending, the combined entity is positioned to lead the way in several areas, including Spine, Trauma, Extremities, Sports Medicine, and more. With the unique blend of technologies and manufacturing capabilities, the new organization aims to bolster the capabilities of Original Equipment Manufacturers (OEMs) significantly. These advancements promise not only to streamline the supply chain but also to uphold high standards of quality and patient care.
Jeff Tyber, the founder and CEO of Tyber Medical, expressed his enthusiasm regarding the merger, highlighting Tyber Medical's impressive track record of launching products within an average of 12 months. He emphasized the advantages that this merger will bring, citing the combination of Intech’s scale and expertise alongside Resolve’s specialties in specific medical fields.
Laurent Pruvost, president and CEO of Intech, also addressed the significance of this merger, stating that it is a crucial step towards becoming the premier partner for medical technology companies worldwide. He noted that the merger will unify their manufacturing prowess with Tyber and Resolve’s tailored solutions, which will elevate the standards of the industry.
Megan Osorio, president and CEO of Resolve Surgical Technologies, reaffirmed the group's commitment to innovation, stating that the merger will ultimately enhance the capability to support their OEM customers efficiently. She believes that merging the strengths of each company will significantly improve their service offerings by integrating deep expertise in various medical sectors.
Montagu’s support for this merger is not only a financial investment but also a commitment to responsible growth in the healthcare sector. The firm specializes in mid-market private equity and aims to nurture businesses that can deliver vital services in expanding markets. They will play a critical role in this merger, which is oriented towards delivering innovative, high-quality solutions to patients and healthcare providers alike.
The financial advisory roles were handled by Houlihan Lokey and Dechert LLP for Tyber Medical, while Weil Gotshal & Manges provided legal guidance to Montagu, Intech, and Resolve. As this merger unfolds, the implications for the medical device sector are potentially vast, promising quicker access to new solutions that enhance patient care and medical outcomes.
As the newly formed entity prepares to take shape, industry experts are keenly observing how it will redefine standards in medical device innovation and manufacturing. With a shared vision and complementary strengths, Tyber Medical, Intech, Resolve, and Montagu are poised to usher in a new era in the medical technology industry that prioritizes both efficacy and patient safety.